Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Active surveillance study of adverse events following immunisation of children in the Czech Republic

J. Danova, A. Kocourkova, AM. Celko,

. 2017 ; 17 (1) : 167. [pub] 20170206

Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Despite the undisputed public health benefits of routine vaccination, adverse events following immunisation (AEFI) remain a concern. As most adverse events are mild, they may be under-reported; this may underlie the wide range of AEFI rates reported in the literature. We investigated the rates of AEFI related to routine vaccination of children 0-10 years old in the Czech Republic. METHODS: The study reviewed patients' records in a sample of 49 paediatric GP practices covering all 12 administrative regions of the Czech Republic between 2011 and 2013. Adverse events following routine immunisation of children aged 0-10 years were identified and recorded. RESULTS: The overall rate of AEFI was 209/100,000 doses; this was 6 times higher than the rate reported to the Czech State Institute for Drug Control (34/100,000 doses). Over two fifths (44%) of all AEFI occurred after the booster dose of the combined diphteria, tetanus and pertussis vaccine in 5-year old children. The vast majority of AEFI were non-serious local events (e.g. redness) and fever. Most AEFI occurred the second day after the immunisation, lasted 4 days on average, and were treated by cold therapy, antipyretics and analgesics. CONCLUSIONS: The rate of AEFI identified in this study was considerably higher than the officially reported rate. Although the vast majority of AEFI were non-serious, health care providers and the public should be educated and encouraged to report AEFI to address the issue of underreporting, to increase the safety profile of vaccines, and to improve public confidence in immunisation programmes.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031064
003      
CZ-PrNML
005      
20171025115422.0
007      
ta
008      
171025s2017 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12889-017-4083-4 $2 doi
035    __
$a (PubMed)28166783
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Danova, Jana $u Department of Epidemiology, Third Faculty of Medicine Charles University, Prague, Czech Republic. jana.danova@lf3.cuni.cz.
245    10
$a Active surveillance study of adverse events following immunisation of children in the Czech Republic / $c J. Danova, A. Kocourkova, AM. Celko,
520    9_
$a BACKGROUND: Despite the undisputed public health benefits of routine vaccination, adverse events following immunisation (AEFI) remain a concern. As most adverse events are mild, they may be under-reported; this may underlie the wide range of AEFI rates reported in the literature. We investigated the rates of AEFI related to routine vaccination of children 0-10 years old in the Czech Republic. METHODS: The study reviewed patients' records in a sample of 49 paediatric GP practices covering all 12 administrative regions of the Czech Republic between 2011 and 2013. Adverse events following routine immunisation of children aged 0-10 years were identified and recorded. RESULTS: The overall rate of AEFI was 209/100,000 doses; this was 6 times higher than the rate reported to the Czech State Institute for Drug Control (34/100,000 doses). Over two fifths (44%) of all AEFI occurred after the booster dose of the combined diphteria, tetanus and pertussis vaccine in 5-year old children. The vast majority of AEFI were non-serious local events (e.g. redness) and fever. Most AEFI occurred the second day after the immunisation, lasted 4 days on average, and were treated by cold therapy, antipyretics and analgesics. CONCLUSIONS: The rate of AEFI identified in this study was considerably higher than the officially reported rate. Although the vast majority of AEFI were non-serious, health care providers and the public should be educated and encouraged to report AEFI to address the issue of underreporting, to increase the safety profile of vaccines, and to improve public confidence in immunisation programmes.
650    _2
$a mladiství $7 D000293
650    _2
$a systémy pro sběr zpráv o nežádoucích účincích léků $x statistika a číselné údaje $7 D016907
650    _2
$a věkové faktory $7 D000367
650    _2
$a dítě $7 D002648
650    _2
$a předškolní dítě $7 D002675
650    _2
$a Česká republika $7 D018153
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a novorozenec $7 D007231
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a surveillance populace $7 D011159
650    _2
$a vakcinace $x škodlivé účinky $7 D014611
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kocourkova, Aneta $u Department of Epidemiology, Third Faculty of Medicine Charles University, Prague, Czech Republic.
700    1_
$a Celko, Alexander M $u Department of Epidemiology, Third Faculty of Medicine Charles University, Prague, Czech Republic.
773    0_
$w MED00008205 $t BMC public health $x 1471-2458 $g Roč. 17, č. 1 (2017), s. 167
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28166783 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025115505 $b ABA008
999    __
$a ok $b bmc $g 1254657 $s 992091
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 17 $c 1 $d 167 $e 20170206 $i 1471-2458 $m BMC public health $n BMC Public Health $x MED00008205
LZP    __
$a Pubmed-20171025

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...